NCT03495089View on ClinicalTrials.gov

DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)

NACompletedINTERVENTIONAL
Enrollment

147

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

September 30, 2018

Conditions
Neuropathy, DiabeticDiabetes Mellitus, Type 2
Interventions
DIAGNOSTIC_TEST

dermal electrochemical conductance (DEC)

The patient will undergo DEC quantification using the Sudoscan® device.(Sudoscan®, Impeto Medical, France)

DIAGNOSTIC_TEST

Monofilament testing

Monofilament testing by Semmes-Weinstein 5:07 MFT (10 g),

Trial Locations (3)

43204

Hospital Universitari Sant Joan de Reus, Reus

08221

Hospital Universitari Mútua Terrassa, Terrassa

Mútua Terrassa Primary Care, Terrassa

All Listed Sponsors
collaborator

Hospital Mutua de Terrassa

OTHER

collaborator

Hospital Universitari Sant Joan de Reus

OTHER

lead

Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

OTHER

NCT03495089 - DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy) | Biotech Hunter | Biotech Hunter